• The "Items Per Page" filter is only for screen display. It does not paginate the export file.
  • Select from the various filters to narrow results.
  • Click the XLS button to download an export file.
Displaying 191 - 200 of 277
Phase 3 Evaluation of the Islatravir (EFdA) Monthly Oral Formulation
Kenya, Malawi, South Africa, Uganda, United States, Zambia, Zimbabwe
Connie Celum
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP
Health Technologies, Molecular Immunology, Pre-exposure Prophylaxis (PrEP)
Paul K. Drain
Population Health Initiative in Peru
Peru
Child and Adolescent Health (incl. Pediatrics), Environmental Health (incl. Climate Change), Health Systems Strengthening and Human Resources Development, Landscape Architecture, Nutrition, Clean Water, and Food Security
Joseph Zunt
Benjamin R. Spencer
Post Treatment Control of HIV infection when treatment is started during primary infection.
United States
HIV/AIDS
Sarah E. Holte
PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis
Kenya
Pre-exposure Prophylaxis (PrEP), STDs (other than HIV)
Jared Baeten
Elizabeth Bukusi
Program in Education and Research in Latin America (PERLA)
Mexico, Peru
Chronic Disease (incl. Cardiovascular, Diabetes), HIV/AIDS, Infectious Diseases (other than STDs), Maternal Child Health (incl. Reproductive Health), STDs (other than HIV)
Joseph Zunt
Progress towards Hepatitis C Elimination in Washington State
United States
Hepatitis
Pamela Kohler
Promotion of COVID-19 Vaccination in Emergency Department (PROCOVAXED)
United States
COVID-19, Drug and Vaccine Development
National Institutes of Health (NIH)
Kelli O'Laughlin

Pages

XLS